Major receptor-binding and neutralization determinants are located within the same domain of the transmissible gastroenteritis virus (coronavirus) spike protein
- PMID: 7525985
- PMCID: PMC237264
- DOI: 10.1128/JVI.68.12.8008-8016.1994
Major receptor-binding and neutralization determinants are located within the same domain of the transmissible gastroenteritis virus (coronavirus) spike protein
Abstract
The spike glycoprotein (S) of coronavirus, the major target for virus-neutralizing antibodies, is assumed to mediate the attachment of virions to the host cell. A 26-kilodalton fragment proteolytically cleaved from transmissible gastroenteritis virus (TGEV) S protein was previously shown to bear two adjacent antigenic sites, A and B, both defined by high-titer neutralizing antibodies. Recombinant baculoviruses expressing C-terminal truncations of the 26-kilodalton region were used to localize functionally important determinants in the S protein primary structure. Two overlapping 223- and 150-amino-acid-long products with serine 506 as a common N terminus expressed all of the site A and B epitopes and induced virus-binding antibodies. Coexpression of one of these truncated protein S derivatives with aminopeptidase N (APN), a cell surface molecule acting as a receptor for TGEV, led to the formation of a complex which could be immunoprecipitated by anti-S antibodies. These data provide evidence that major neutralization-mediating and receptor-binding determinants reside together within a domain of the S protein which behaves like an independent module. In spite of their ability to prevent S-APN interaction, the neutralizing antibodies appeared to recognize a preformed complex, thus indicating that antibody- and receptor-binding determinants should be essentially distinct. Together these findings bring new insight into the molecular mechanism of TGEV neutralization.
Similar articles
-
Functional domains in the spike protein of transmissible gastroenteritis virus.Adv Exp Med Biol. 1995;380:299-304. doi: 10.1007/978-1-4615-1899-0_48. Adv Exp Med Biol. 1995. PMID: 8830497
-
Induction of antibodies protecting against transmissible gastroenteritis coronavirus (TGEV) by recombinant adenovirus expressing TGEV spike protein.Virology. 1995 Nov 10;213(2):503-16. doi: 10.1006/viro.1995.0023. Virology. 1995. PMID: 7491775 Free PMC article.
-
Antigenic modules in the N-terminal S1 region of the transmissible gastroenteritis virus spike protein.J Gen Virol. 2011 May;92(Pt 5):1117-1126. doi: 10.1099/vir.0.027607-0. Epub 2011 Jan 12. J Gen Virol. 2011. PMID: 21228126 Free PMC article.
-
Determinants essential for the transmissible gastroenteritis virus-receptor interaction reside within a domain of aminopeptidase-N that is distinct from the enzymatic site.J Virol. 1994 Aug;68(8):5216-24. doi: 10.1128/JVI.68.8.5216-5224.1994. J Virol. 1994. PMID: 7913510 Free PMC article.
-
Looking for a needle in a haystack: Cellular proteins that may interact with the tyrosine-based sorting signal of the TGEV S protein.Virus Res. 2015 Apr 16;202:3-11. doi: 10.1016/j.virusres.2014.11.029. Epub 2014 Dec 4. Virus Res. 2015. PMID: 25481285 Free PMC article. Review.
Cited by
-
A Nanobody of PEDV S1 Protein: Screening and Expression in Escherichia coli.Biomolecules. 2024 Sep 4;14(9):1116. doi: 10.3390/biom14091116. Biomolecules. 2024. PMID: 39334881 Free PMC article.
-
A single C-terminal residue controls SARS-CoV-2 spike trafficking and incorporation into VLPs.Nat Commun. 2023 Dec 15;14(1):8358. doi: 10.1038/s41467-023-44076-3. Nat Commun. 2023. PMID: 38102143 Free PMC article.
-
Porcine Epidemic Diarrhea Virus: An Updated Overview of Virus Epidemiology, Virulence Variation Patterns and Virus-Host Interactions.Viruses. 2022 Nov 2;14(11):2434. doi: 10.3390/v14112434. Viruses. 2022. PMID: 36366532 Free PMC article. Review.
-
PEDV: Insights and Advances into Types, Function, Structure, and Receptor Recognition.Viruses. 2022 Aug 9;14(8):1744. doi: 10.3390/v14081744. Viruses. 2022. PMID: 36016366 Free PMC article. Review.
-
Spike Glycoprotein Is Central to Coronavirus Pathogenesis-Parallel Between m-CoV and SARS-CoV-2.Ann Neurosci. 2021 Jul;28(3-4):201-218. doi: 10.1177/09727531211023755. Epub 2021 Oct 12. Ann Neurosci. 2021. PMID: 35341224 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous